Trifluoroacetic acid → HCID 178512988, compound
Reaction equation
C([O:5][C:6](=[O:42])[C@@H:7]([NH:32][S:33]([C:36]1[CH:41]=[CH:40][CH:39]=[CH:38][CH:37]=1)(=[O:35])=[O:34])[CH2:8][NH:9][C:10]([NH:12][C:13]1[C:22](=[O:23])[N:21]2[C:16]([CH:17]=[CH:18][C:19]([O:24][CH2:25][CH2:26][CH2:27][NH:28][C:29]([NH2:31])=[NH:30])=[CH:20]2)=[CH:15][CH:14]=1)=[O:11])(C)(C)C.[F:43][C:44]([F:49])([F:48])[C:45]([OH:47])=[O:46]>ClCCl>[F:43][C:44]([F:49])([F:48])[C:45]([OH:47])=[O:46].[C:36]1([S:33]([NH:32][C@@H:7]([CH2:8][NH:9][C:10]([NH:12][C:13]2[C:22](=[O:23])[N:21]3[C:16]([CH:17]=[CH:18][C:19]([O:24][CH2:25][CH2:26][CH2:27][NH:28][C:29]([NH2:31])=[NH:30])=[CH:20]3)=[CH:15][CH:14]=2)=[O:11])[C:6]([OH:42])=[O:5])(=[O:35])=[O:34])[CH:41]=[CH:40][CH:39]=[CH:38][CH:37]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a suspension (S)-2-benzenesulfonylamino-3-{3-[7-(3-guanidino-propoxy)-4-oxo-4H-quinolizin-3-yl]-ureido}-propionic acid tert-butyl ester (30 mg, 0.049 mmol) in dichloromethane (4 mL) was added trifluoroacetic acid (6 mL). The mixture was stirred overnight, evaporated to dryness and triturated in ether (3X) and hexane (1X). Compound IX was purified by preparative HPLC using 1:1 MeCN:H2O as eluent and characterized by 1H NMR (400 MHz) (CD3OD) d: 8.51 (d, 1H, J=8.5 Hz), 8.45 (s, 1H), 7.98-7.85 (m, 2H), 7.63 (d, 1H, J=9 Hz), 7.49-7.47 (m, 3H), 7.10 (d, 1H, J=9 Hz), 6.98 (d, 1H, J=8.5 Hz), 4.20 (t, 2H, J=5.5 Hz), 4.03-4.01 (m, 1H), 3.65-3.62 (m, 1H), 3.49-3.42 (m, 3H), 2.20-2.14 (m, 2H)
Workup
- customevaporated to dryness
- customtriturated in ether (3X)
- customCompound IX was purified by preparative HPLC
Sources & evidence
- ORD record
- ord-74c7c1f2f555401c9e0d10afc918a03c
- Source dataset
- uspto-grants-2003_10
- Patent number
- US06630488B1
Reaction notes
Loading…